posted on 2025-01-10, 20:21authored byOmotayo Farinre, Tzoalli Anaya, Alexis C. King, Kedan Endrias, Anne H. Hébert, Alison L. Hill, Sherrie Jean, Jennifer S. Wood, Stephanie Ehnert, Shan Liang, Gregory M. Laird, Rosemarie D. Mason, Mario Roederer, Jeffrey T. Safrit, Maud Mavigner, Ann Chahroudi
Values represent mean and 95% confidence intervals of estimated parameters from a mixed effects biexponential decay model. Relative to the baseline ART only group (first column), treatment effects for both SIV RhmAbs and N-803 were estimated (second and third column), which contribute to the overall parameters for the ART + SIV RhmAbs and ART + SIV RhmAbs + N-803 groups (fourth and fifth columns). For treatment effects, blank cells indicate that no significant effect of the treatment on that parameter was identified. Half-lives were calculated from decay rates as T1/2 = ln(2)/b.